Our portfolio includes many high performers with significant upside potential. In particular, we target companies with strong and experienced management teams, innovative products in or close to clinical trials, solid proofs of concept and strong IP protection.

Filter Categories
Show all
Medical Devices
Therapeutics
Diagnostics
Digital Health
Filter Categories
Show all
Active
Exited